We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
-14.42%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$39.8B
AUM Growth
-$8.63B
Cap. Flow
-$1.64B
Cap. Flow %
-4.13%
Top 10 Hldgs %
6.94%
Holding
1,861
New
72
Increased
819
Reduced
764
Closed
84

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$166M
2
PSA icon
Public Storage
PSA
+$151M
3
KMB icon
Kimberly-Clark
KMB
+$144M
4
PB icon
Prosperity Bancshares
PB
+$88.6M
5
EMN icon
Eastman Chemical
EMN
+$83.2M

Sector Composition

Rank Sector Weight
1 Financials 18.45%
2 Industrials 14.09%
3 Technology 13.91%
4 Consumer Discretionary 11.58%
5 Healthcare 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FOMX
1701
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$15K ﹤0.01%
4,125
OLBK
1702
DELISTED
Old Line Bancshares, Inc.
OLBK
$15K ﹤0.01%
561
DVAX
1703
DELISTED
Dynavax Technologies
DVAX
$14K ﹤0.01%
1,505
-287
-16% -$3.18K
ESPR
1704
DELISTED
Esperion Therapeutics
ESPR
$13K ﹤0.01%
273
-52
-16% -$2.5K
IWM icon
1705
iShares Russell 2000 ETF
IWM
$83B
$13K ﹤0.01%
95
IWR icon
1706
iShares Russell Mid-Cap ETF
IWR
$57.4B
$13K ﹤0.01%
276
KFY icon
1707
Korn Ferry
KFY
$4.28B
$13K ﹤0.01%
323
LCNB icon
1708
LCNB Corp
LCNB
$283M
$13K ﹤0.01%
833
TBCH
1709
Turtle Beach Corp
TBCH
$277M
$13K ﹤0.01%
+907
New +$15.6K
BVH
1710
DELISTED
Bluegreen Vacations Holding Corporation
BVH
$13K ﹤0.01%
454
NEWR
1711
DELISTED
New Relic, Inc.
NEWR
$13K ﹤0.01%
165
QUOT
1712
DELISTED
Quotient Technology Inc
QUOT
$13K ﹤0.01%
1,221
CASH icon
1713
Pathward Financial
CASH
$1.8B
$11K ﹤0.01%
546
CLLS
1714
Cellectis
CLLS
$285M
$11K ﹤0.01%
660
-126
-16% -$2.92K
LXRX icon
1715
Lexicon Pharmaceuticals
LXRX
$1.1B
$10K ﹤0.01%
1,505
-287
-16% -$2.33K
GMDA
1716
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$10K ﹤0.01%
+1,000
New +$10.8K
CBAY
1717
DELISTED
Cymabay Therapeutics
CBAY
$10K ﹤0.01%
1,278
-244
-16% -$2.32K
BNGOW
1718
DELISTED
Bionano Genomics, Inc. Warrant
BNGOW
$10K ﹤0.01%
8,136
EXP icon
1719
Eagle Materials
EXP
$6.57B
$9K ﹤0.01%
149
TGTX icon
1720
TG Therapeutics
TGTX
$7.62B
$9K ﹤0.01%
2,119
ABEO icon
1721
Abeona Therapeutics
ABEO
$413M
$8K ﹤0.01%
43
ADMS
1722
DELISTED
Adamas Pharmaceuticals
ADMS
$8K ﹤0.01%
973
SPB icon
1723
Spectrum Brands
SPB
$2.07B
$7K ﹤0.01%
154
-622
-80% -$35.9K
CDTX
1724
DELISTED
Cidara Therapeutics
CDTX
$6K ﹤0.01%
127
WPG
1725
DELISTED
Washington Prime Group Inc.
WPG
$5K ﹤0.01%
114

Similar funds

Victory Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, Victory Capital Management held 1,861 positions worth $39.8B, down 18% from $48.5B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

Victory Capital Management withdrew a net $1.64B in Q4 2018, closing 84 positions and reducing 764 holdings. Its most notable exit was ARRIS International plc Ordinary Shares, an estimated $137M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Victory Capital Management opened a new position in Sprouts Farmers Market worth $53.3M.

  • Victory Capital Management's largest Q4 2018 buy was Sprouts Farmers Market: 2,268,450 shares worth $53.3M.
  • Victory Capital Management added most to Cencora in Q4 2018, an estimated $166M increase.
  • Victory Capital Management's biggest Q4 2018 reduction was Perrigo, cutting an estimated $187M.
  • Victory Capital Management fully exited ARRIS International plc Ordinary Shares in Q4 2018, selling an estimated $137M.
  • Victory Capital Management's ten largest holdings make up 6.9% of its $39.8B portfolio in Q4 2018.
  • Victory Capital Management opened 72 new positions and closed 84 in Q4 2018.
  • Victory Capital Management's portfolio value fell 18% quarter-over-quarter to $39.8B.

Based on Victory Capital Management's 13F filing for Q4 2018, filed 5 Feb 2019.